Phenoxybenzamine hydrochloride是非特异性的不可逆的α肾上腺素受体长效拮抗剂。
Phenoxybenzamine HCl is a non-specific, irreversible alpha antagonist with an IC50 of 550 nM.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Chew, S.L. 2004. Expert Opin Investig Drugs. 13: 1579-1583. PMID: 15566315
[2] Earl, C.Q., et al. 1984. Life Sci. 35: 525-534. PMID: 6146911
[3] Frang, H., et al. 2001. J. Biol. Chem. 276: 31279-31284. PMID: 11395517
[4] Ning, Y.M., et al. 1996. Mol. Endocrinol. 10: 14-23. PMID: 8838141
分子式 C18H23Cl2NO |
分子量 340.29 |
CAS号 63-92-3 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 68 mg/mL |
Water 15 mg/mL |
Ethanol 68 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00620945 | Congenital Heart Surgery|Cardiopulmonary Bypass | Drug: Phenoxybenzamine | The Cleveland Clinic | 2006-06-01 | 2008-02-11 | |
NCT00569855 | Open-heart Surgery|Cardiopulmonary Bypass | Drug: Phenoxybenzamine | University of Arkansas|Arkansas Children's Hospital Research Institute | Phase 2 | 2001-02-01 | 2011-02-03 |
NCT01379898 | Pheochromocytoma | Drug: Phenoxybenzamine|Drug: Doxazosin | University Medical Center Groningen|Radboud University|UMC Utrecht|VU University of Amsterdam|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Leiden University Medical Center|Erasmus Medical Center|Maastricht University Medical Center|St. Antonius Hospital|Medisch Spectrum Twente|Maxima Medical Center|Canisius-Wilhelmina Hospital|Onze Lieve Vrouwe Gasthuis|Atrium Medical Center|Isala | Phase 4 | 2011-12-01 | 2016-10-25 |
NCT00770705 | Congenital Heart Disease | Drug: Phenoxybenzamine|Other: Standard surgical approach | Vanderbilt University | Phase 2 | 2008-10-01 | 2008-10-09 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们